IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma

Identical twins of young adult Hodgkin lymphoma case subjects are much more likely to develop the disease compared with fraternal twins of case subjects, suggesting a genetic determinant. Interleukin 6 (IL-6) levels are increased in patients with Hodgkin lymphoma and are correlated with a poor progn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2004-04, Vol.103 (8), p.3216-3221
Hauptverfasser: Cozen, Wendy, Gill, Parkash S., Ingles, Sue Ann, Masood, Rizwan, Martínez-Maza, Otoniel, Cockburn, Myles G., Gauderman, W. James, Pike, Malcolm C., Bernstein, Leslie, Nathwani, Bharat N., Salam, Muhammad T., Danley, Kathleen Lackerdas, Wang, Wei, Gage, Julia, Gundell-Miller, Susan, Mack, Thomas M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3221
container_issue 8
container_start_page 3216
container_title Blood
container_volume 103
creator Cozen, Wendy
Gill, Parkash S.
Ingles, Sue Ann
Masood, Rizwan
Martínez-Maza, Otoniel
Cockburn, Myles G.
Gauderman, W. James
Pike, Malcolm C.
Bernstein, Leslie
Nathwani, Bharat N.
Salam, Muhammad T.
Danley, Kathleen Lackerdas
Wang, Wei
Gage, Julia
Gundell-Miller, Susan
Mack, Thomas M.
description Identical twins of young adult Hodgkin lymphoma case subjects are much more likely to develop the disease compared with fraternal twins of case subjects, suggesting a genetic determinant. Interleukin 6 (IL-6) levels are increased in patients with Hodgkin lymphoma and are correlated with a poor prognosis. We hypothesized that a heritable abnormality in IL-6 regulation may predispose to young adult Hodgkin lymphoma. We obtained blood specimens from 88 young adult Hodgkin lymphoma case subjects and their twins as well as from 87 matched control subjects. IL-6 was measured from unstimulated peripheral blood mononuclear cell (PBMC) supernatant with enzyme-linked immunosorbent assays (ELISAs) and compared by using analysis of covariance. Unaffected identical twins of case subjects (surrogate case subjects) had a 87.8% higher IL-6 level compared with matched control subjects (mean difference, +483.7 pg/mL,P= .04). Analysis of the IL-6 174G>C promoter polymorphism genotypes showed that risk decreased with an increasing number of C alleles (P= .01). The CC (low secreting) genotype was associated with a decreased risk of young adult Hodgkin lymphoma relative to the GG (high secreting) genotype (odds ratio [OR] = .29;P= .03). Risk was decreased for both nodular sclerosis and other subtypes. Persons with genetically determined lower IL-6 levels may be less susceptible to young adult Hodgkin lymphoma. (Blood. 2004;103:3216-3221)
doi_str_mv 10.1182/blood-2003-08-2860
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71812987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120438224</els_id><sourcerecordid>71812987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-e25a7f3cff565c4ea6691a0aed0c55534bf69e825888dc8fbbb5a2157ebe55ef3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVpaDZJ_0APRZf2pnQkW7YWeimh-YCFUmjOQpZGGzWytZHshP338WYXklMYhrk878vwEPKFwznnSvzoYkqOCYCKgWJCNfCBLLgUigEI-EgWANCwetnyY3JSyn8AXldCfiLHXEI7j1yQvzcr1tCIjxgLNYOjaxzSuN0gNXneUpINZkRHn8J4R3Mo9zR5uk3TsKbGTXGk18mt78NA47bf3KXenJEjb2LBz4d7Sm4vf_-7uGarP1c3F79WzFaqHhkKaVpfWe9lI22NpmmW3IBBB1ZKWdWdb5aohFRKOat813XSCC5b7FBK9NUp-b7v3eT0MGEZdR-KxRjNgGkquuWKi6VqZ1DsQZtTKRm93uTQm7zVHPROpH4RqXciNSi9EzmHvh7ap65H9xo5mJuBbwfAFGuiz2awobzhFDQV1DP3c8_NgvExYNbFBhwsupDRjtql8N4fz64NkVk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71812987</pqid></control><display><type>article</type><title>IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Cozen, Wendy ; Gill, Parkash S. ; Ingles, Sue Ann ; Masood, Rizwan ; Martínez-Maza, Otoniel ; Cockburn, Myles G. ; Gauderman, W. James ; Pike, Malcolm C. ; Bernstein, Leslie ; Nathwani, Bharat N. ; Salam, Muhammad T. ; Danley, Kathleen Lackerdas ; Wang, Wei ; Gage, Julia ; Gundell-Miller, Susan ; Mack, Thomas M.</creator><creatorcontrib>Cozen, Wendy ; Gill, Parkash S. ; Ingles, Sue Ann ; Masood, Rizwan ; Martínez-Maza, Otoniel ; Cockburn, Myles G. ; Gauderman, W. James ; Pike, Malcolm C. ; Bernstein, Leslie ; Nathwani, Bharat N. ; Salam, Muhammad T. ; Danley, Kathleen Lackerdas ; Wang, Wei ; Gage, Julia ; Gundell-Miller, Susan ; Mack, Thomas M.</creatorcontrib><description>Identical twins of young adult Hodgkin lymphoma case subjects are much more likely to develop the disease compared with fraternal twins of case subjects, suggesting a genetic determinant. Interleukin 6 (IL-6) levels are increased in patients with Hodgkin lymphoma and are correlated with a poor prognosis. We hypothesized that a heritable abnormality in IL-6 regulation may predispose to young adult Hodgkin lymphoma. We obtained blood specimens from 88 young adult Hodgkin lymphoma case subjects and their twins as well as from 87 matched control subjects. IL-6 was measured from unstimulated peripheral blood mononuclear cell (PBMC) supernatant with enzyme-linked immunosorbent assays (ELISAs) and compared by using analysis of covariance. Unaffected identical twins of case subjects (surrogate case subjects) had a 87.8% higher IL-6 level compared with matched control subjects (mean difference, +483.7 pg/mL,P= .04). Analysis of the IL-6 174G&gt;C promoter polymorphism genotypes showed that risk decreased with an increasing number of C alleles (P= .01). The CC (low secreting) genotype was associated with a decreased risk of young adult Hodgkin lymphoma relative to the GG (high secreting) genotype (odds ratio [OR] = .29;P= .03). Risk was decreased for both nodular sclerosis and other subtypes. Persons with genetically determined lower IL-6 levels may be less susceptible to young adult Hodgkin lymphoma. (Blood. 2004;103:3216-3221)</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2003-08-2860</identifier><identifier>PMID: 15070705</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Base Sequence ; Biological and medical sciences ; Case-Control Studies ; Diseases in Twins - genetics ; DNA, Complementary - genetics ; Female ; Genotype ; Hematologic and hematopoietic diseases ; Hodgkin Disease - blood ; Hodgkin Disease - genetics ; Hodgkin Disease - immunology ; Humans ; Interleukin-6 - blood ; Interleukin-6 - genetics ; Interleukin-6 - metabolism ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Polymorphism, Genetic ; Risk Factors ; Twins, Dizygotic ; Twins, Monozygotic</subject><ispartof>Blood, 2004-04, Vol.103 (8), p.3216-3221</ispartof><rights>2004 American Society of Hematology</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-e25a7f3cff565c4ea6691a0aed0c55534bf69e825888dc8fbbb5a2157ebe55ef3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15806304$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15070705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cozen, Wendy</creatorcontrib><creatorcontrib>Gill, Parkash S.</creatorcontrib><creatorcontrib>Ingles, Sue Ann</creatorcontrib><creatorcontrib>Masood, Rizwan</creatorcontrib><creatorcontrib>Martínez-Maza, Otoniel</creatorcontrib><creatorcontrib>Cockburn, Myles G.</creatorcontrib><creatorcontrib>Gauderman, W. James</creatorcontrib><creatorcontrib>Pike, Malcolm C.</creatorcontrib><creatorcontrib>Bernstein, Leslie</creatorcontrib><creatorcontrib>Nathwani, Bharat N.</creatorcontrib><creatorcontrib>Salam, Muhammad T.</creatorcontrib><creatorcontrib>Danley, Kathleen Lackerdas</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Gage, Julia</creatorcontrib><creatorcontrib>Gundell-Miller, Susan</creatorcontrib><creatorcontrib>Mack, Thomas M.</creatorcontrib><title>IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma</title><title>Blood</title><addtitle>Blood</addtitle><description>Identical twins of young adult Hodgkin lymphoma case subjects are much more likely to develop the disease compared with fraternal twins of case subjects, suggesting a genetic determinant. Interleukin 6 (IL-6) levels are increased in patients with Hodgkin lymphoma and are correlated with a poor prognosis. We hypothesized that a heritable abnormality in IL-6 regulation may predispose to young adult Hodgkin lymphoma. We obtained blood specimens from 88 young adult Hodgkin lymphoma case subjects and their twins as well as from 87 matched control subjects. IL-6 was measured from unstimulated peripheral blood mononuclear cell (PBMC) supernatant with enzyme-linked immunosorbent assays (ELISAs) and compared by using analysis of covariance. Unaffected identical twins of case subjects (surrogate case subjects) had a 87.8% higher IL-6 level compared with matched control subjects (mean difference, +483.7 pg/mL,P= .04). Analysis of the IL-6 174G&gt;C promoter polymorphism genotypes showed that risk decreased with an increasing number of C alleles (P= .01). The CC (low secreting) genotype was associated with a decreased risk of young adult Hodgkin lymphoma relative to the GG (high secreting) genotype (odds ratio [OR] = .29;P= .03). Risk was decreased for both nodular sclerosis and other subtypes. Persons with genetically determined lower IL-6 levels may be less susceptible to young adult Hodgkin lymphoma. (Blood. 2004;103:3216-3221)</description><subject>Adolescent</subject><subject>Adult</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Diseases in Twins - genetics</subject><subject>DNA, Complementary - genetics</subject><subject>Female</subject><subject>Genotype</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hodgkin Disease - blood</subject><subject>Hodgkin Disease - genetics</subject><subject>Hodgkin Disease - immunology</subject><subject>Humans</subject><subject>Interleukin-6 - blood</subject><subject>Interleukin-6 - genetics</subject><subject>Interleukin-6 - metabolism</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Polymorphism, Genetic</subject><subject>Risk Factors</subject><subject>Twins, Dizygotic</subject><subject>Twins, Monozygotic</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVpaDZJ_0APRZf2pnQkW7YWeimh-YCFUmjOQpZGGzWytZHshP338WYXklMYhrk878vwEPKFwznnSvzoYkqOCYCKgWJCNfCBLLgUigEI-EgWANCwetnyY3JSyn8AXldCfiLHXEI7j1yQvzcr1tCIjxgLNYOjaxzSuN0gNXneUpINZkRHn8J4R3Mo9zR5uk3TsKbGTXGk18mt78NA47bf3KXenJEjb2LBz4d7Sm4vf_-7uGarP1c3F79WzFaqHhkKaVpfWe9lI22NpmmW3IBBB1ZKWdWdb5aohFRKOat813XSCC5b7FBK9NUp-b7v3eT0MGEZdR-KxRjNgGkquuWKi6VqZ1DsQZtTKRm93uTQm7zVHPROpH4RqXciNSi9EzmHvh7ap65H9xo5mJuBbwfAFGuiz2awobzhFDQV1DP3c8_NgvExYNbFBhwsupDRjtql8N4fz64NkVk</recordid><startdate>20040415</startdate><enddate>20040415</enddate><creator>Cozen, Wendy</creator><creator>Gill, Parkash S.</creator><creator>Ingles, Sue Ann</creator><creator>Masood, Rizwan</creator><creator>Martínez-Maza, Otoniel</creator><creator>Cockburn, Myles G.</creator><creator>Gauderman, W. James</creator><creator>Pike, Malcolm C.</creator><creator>Bernstein, Leslie</creator><creator>Nathwani, Bharat N.</creator><creator>Salam, Muhammad T.</creator><creator>Danley, Kathleen Lackerdas</creator><creator>Wang, Wei</creator><creator>Gage, Julia</creator><creator>Gundell-Miller, Susan</creator><creator>Mack, Thomas M.</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040415</creationdate><title>IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma</title><author>Cozen, Wendy ; Gill, Parkash S. ; Ingles, Sue Ann ; Masood, Rizwan ; Martínez-Maza, Otoniel ; Cockburn, Myles G. ; Gauderman, W. James ; Pike, Malcolm C. ; Bernstein, Leslie ; Nathwani, Bharat N. ; Salam, Muhammad T. ; Danley, Kathleen Lackerdas ; Wang, Wei ; Gage, Julia ; Gundell-Miller, Susan ; Mack, Thomas M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-e25a7f3cff565c4ea6691a0aed0c55534bf69e825888dc8fbbb5a2157ebe55ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Diseases in Twins - genetics</topic><topic>DNA, Complementary - genetics</topic><topic>Female</topic><topic>Genotype</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hodgkin Disease - blood</topic><topic>Hodgkin Disease - genetics</topic><topic>Hodgkin Disease - immunology</topic><topic>Humans</topic><topic>Interleukin-6 - blood</topic><topic>Interleukin-6 - genetics</topic><topic>Interleukin-6 - metabolism</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Polymorphism, Genetic</topic><topic>Risk Factors</topic><topic>Twins, Dizygotic</topic><topic>Twins, Monozygotic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cozen, Wendy</creatorcontrib><creatorcontrib>Gill, Parkash S.</creatorcontrib><creatorcontrib>Ingles, Sue Ann</creatorcontrib><creatorcontrib>Masood, Rizwan</creatorcontrib><creatorcontrib>Martínez-Maza, Otoniel</creatorcontrib><creatorcontrib>Cockburn, Myles G.</creatorcontrib><creatorcontrib>Gauderman, W. James</creatorcontrib><creatorcontrib>Pike, Malcolm C.</creatorcontrib><creatorcontrib>Bernstein, Leslie</creatorcontrib><creatorcontrib>Nathwani, Bharat N.</creatorcontrib><creatorcontrib>Salam, Muhammad T.</creatorcontrib><creatorcontrib>Danley, Kathleen Lackerdas</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Gage, Julia</creatorcontrib><creatorcontrib>Gundell-Miller, Susan</creatorcontrib><creatorcontrib>Mack, Thomas M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cozen, Wendy</au><au>Gill, Parkash S.</au><au>Ingles, Sue Ann</au><au>Masood, Rizwan</au><au>Martínez-Maza, Otoniel</au><au>Cockburn, Myles G.</au><au>Gauderman, W. James</au><au>Pike, Malcolm C.</au><au>Bernstein, Leslie</au><au>Nathwani, Bharat N.</au><au>Salam, Muhammad T.</au><au>Danley, Kathleen Lackerdas</au><au>Wang, Wei</au><au>Gage, Julia</au><au>Gundell-Miller, Susan</au><au>Mack, Thomas M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2004-04-15</date><risdate>2004</risdate><volume>103</volume><issue>8</issue><spage>3216</spage><epage>3221</epage><pages>3216-3221</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Identical twins of young adult Hodgkin lymphoma case subjects are much more likely to develop the disease compared with fraternal twins of case subjects, suggesting a genetic determinant. Interleukin 6 (IL-6) levels are increased in patients with Hodgkin lymphoma and are correlated with a poor prognosis. We hypothesized that a heritable abnormality in IL-6 regulation may predispose to young adult Hodgkin lymphoma. We obtained blood specimens from 88 young adult Hodgkin lymphoma case subjects and their twins as well as from 87 matched control subjects. IL-6 was measured from unstimulated peripheral blood mononuclear cell (PBMC) supernatant with enzyme-linked immunosorbent assays (ELISAs) and compared by using analysis of covariance. Unaffected identical twins of case subjects (surrogate case subjects) had a 87.8% higher IL-6 level compared with matched control subjects (mean difference, +483.7 pg/mL,P= .04). Analysis of the IL-6 174G&gt;C promoter polymorphism genotypes showed that risk decreased with an increasing number of C alleles (P= .01). The CC (low secreting) genotype was associated with a decreased risk of young adult Hodgkin lymphoma relative to the GG (high secreting) genotype (odds ratio [OR] = .29;P= .03). Risk was decreased for both nodular sclerosis and other subtypes. Persons with genetically determined lower IL-6 levels may be less susceptible to young adult Hodgkin lymphoma. (Blood. 2004;103:3216-3221)</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>15070705</pmid><doi>10.1182/blood-2003-08-2860</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2004-04, Vol.103 (8), p.3216-3221
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_71812987
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Base Sequence
Biological and medical sciences
Case-Control Studies
Diseases in Twins - genetics
DNA, Complementary - genetics
Female
Genotype
Hematologic and hematopoietic diseases
Hodgkin Disease - blood
Hodgkin Disease - genetics
Hodgkin Disease - immunology
Humans
Interleukin-6 - blood
Interleukin-6 - genetics
Interleukin-6 - metabolism
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical sciences
Middle Aged
Polymorphism, Genetic
Risk Factors
Twins, Dizygotic
Twins, Monozygotic
title IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A16%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IL-6%20levels%20and%20genotype%20are%20associated%20with%20risk%20of%20young%20adult%20Hodgkin%20lymphoma&rft.jtitle=Blood&rft.au=Cozen,%20Wendy&rft.date=2004-04-15&rft.volume=103&rft.issue=8&rft.spage=3216&rft.epage=3221&rft.pages=3216-3221&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2003-08-2860&rft_dat=%3Cproquest_cross%3E71812987%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71812987&rft_id=info:pmid/15070705&rft_els_id=S0006497120438224&rfr_iscdi=true